• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用适应低温培养的稳定昆虫细胞在高细胞密度下强化连续生产Gag-HA病毒样颗粒

Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.

作者信息

Fernandes Bárbara, Correia Ricardo, Alves Paula M, Roldão António

机构信息

IBET-Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.

Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.

出版信息

Front Bioeng Biotechnol. 2022 Jun 29;10:917746. doi: 10.3389/fbioe.2022.917746. eCollection 2022.

DOI:10.3389/fbioe.2022.917746
PMID:35845394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9277389/
Abstract

Protein production processes based on stable insect cell lines require intensification to be competitive with the insect cell-baculovirus expression vector system (IC-BEVS). High cell density (HCD) cultures operate continuously, capable of maintaining specific production rates for extended periods of time which may lead to significant improvements in production yields. However, setting up such processes is challenging (e.g., selection of cell retention device and optimization of dilution rate), often demanding the manipulation of large volumes of culture medium with associated high cost. In this study, we developed a process for continuous production of Gag virus-like particles (VLP) pseudotyped with a model membrane protein (influenza hemagglutinin, HA) at HCD using stable insect cells adapted to low culture temperature. The impact of the cell retention device (ATF vs. TFF) and cell-specific perfusion rate (CSPR) on cell growth and protein expression kinetics was evaluated. Continuous production of Gag-HA VLPs was possible using both retention devices and CSPR of 0.04 nL/cell.d; TFF induces higher cell lysis when compared to ATF at later stages of the process (k = 0.009 vs. 0.005 h, for TFF and ATF, respectively). Reducing CSPR to 0.01-0.02 nL/cell.d using ATF had a negligible impact on specific production rates (r = 72-68 titer/10 cell.h and r = 12-11 pg/10 cell.h in all CSPR) and on particle morphology (round-shaped structures displaying HA spikes on their surface) and size distribution profile (peaks at approximately 100 nm). Notably, at these CSPRs, the amount of p24 or HA formed per volume of culture medium consumed per unit of process time increases by up to 3-fold when compared to batch and perfusion operation modes. Overall, this work demonstrates the potential of manipulating CSPRs to intensify the continuous production of Gag-HA VLPs at HCD using stable insect cells to make them an attractive alternative platform to IC-BEVS.

摘要

基于稳定昆虫细胞系的蛋白质生产工艺需要强化,以使其能与昆虫细胞-杆状病毒表达载体系统(IC-BEVS)竞争。高细胞密度(HCD)培养可连续运行,能够长时间维持特定生产率,这可能会显著提高产量。然而,建立这样的工艺具有挑战性(例如,细胞截留装置的选择和稀释率的优化),通常需要处理大量培养基,成本高昂。在本研究中,我们开发了一种在HCD条件下,使用适应低温培养的稳定昆虫细胞连续生产以模型膜蛋白(流感血凝素,HA)假型化的Gag病毒样颗粒(VLP)的工艺。评估了细胞截留装置(交替切向流过滤(ATF)与切向流过滤(TFF))和细胞特异性灌注速率(CSPR)对细胞生长和蛋白质表达动力学的影响。使用两种截留装置和0.04 nL/细胞·天的CSPR都可以连续生产Gag-HA VLP;在工艺后期,与ATF相比,TFF诱导更高的细胞裂解(TFF和ATF的k分别为0.009 h⁻¹和0.005 h⁻¹)。使用ATF将CSPR降低到0.01 - 0.02 nL/细胞·天对特定生产率(所有CSPR下r = 72 - 68效价/10⁶细胞·小时和r = 12 - 11 pg/10⁶细胞·小时)以及颗粒形态(表面显示HA刺突的圆形结构)和尺寸分布曲线(峰值约为100 nm)的影响可忽略不计。值得注意的是,在这些CSPR下,与分批和灌注操作模式相比,单位工艺时间内每消耗单位体积培养基形成的p24或HA量增加了高达3倍。总体而言,这项工作证明了通过控制CSPR来强化使用稳定昆虫细胞在HCD条件下连续生产Gag-HA VLP的潜力,使其成为IC-BEVS有吸引力的替代平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/947b52ac38bd/fbioe-10-917746-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/7ba1055d7bc3/fbioe-10-917746-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/b42a7c43231f/fbioe-10-917746-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/7909ba753add/fbioe-10-917746-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/b291cf5febe4/fbioe-10-917746-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/947b52ac38bd/fbioe-10-917746-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/7ba1055d7bc3/fbioe-10-917746-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/b42a7c43231f/fbioe-10-917746-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/7909ba753add/fbioe-10-917746-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/b291cf5febe4/fbioe-10-917746-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2039/9277389/947b52ac38bd/fbioe-10-917746-g005.jpg

相似文献

1
Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.利用适应低温培养的稳定昆虫细胞在高细胞密度下强化连续生产Gag-HA病毒样颗粒
Front Bioeng Biotechnol. 2022 Jun 29;10:917746. doi: 10.3389/fbioe.2022.917746. eCollection 2022.
2
Integrating high cell density cultures with adapted laboratory evolution for improved Gag-HA virus-like particles production in stable insect cell lines.将高密度细胞培养与适应性实验室进化相结合,以提高稳定昆虫细胞系中 Gag-HA 病毒样颗粒的产量。
Biotechnol Bioeng. 2021 Jul;118(7):2536-2547. doi: 10.1002/bit.27766. Epub 2021 Apr 8.
3
Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.利用可诱导的HEK-293稳定细胞系实现高产甲型H1N1流感病毒核衣壳蛋白病毒样颗粒的过程强化
Vaccine. 2017 Jul 24;35(33):4220-4228. doi: 10.1016/j.vaccine.2017.06.024. Epub 2017 Jun 22.
4
Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.将稳定昆虫细胞系与杆状病毒介导的表达相结合,用于生产多 HA 流感 VLPs。
Vaccine. 2018 May 24;36(22):3112-3123. doi: 10.1016/j.vaccine.2017.02.043. Epub 2017 Mar 11.
5
Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.在HEK-293悬浮培养中产生的含有血凝素和神经氨酸酶的病毒样颗粒:一种有效的流感疫苗候选物。
Vaccine. 2016 Jun 17;34(29):3371-80. doi: 10.1016/j.vaccine.2016.04.089. Epub 2016 May 5.
6
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.用于高细胞密度和连续多阶段培养的生物反应器:基于细胞培养的病毒疫苗生产中的过程强化选项。
Appl Microbiol Biotechnol. 2016 Mar;100(5):2121-32. doi: 10.1007/s00253-015-7267-9. Epub 2016 Jan 13.
7
Improving Influenza HA-Vlps Production in Insect High Five Cells via Adaptive Laboratory Evolution.通过适应性实验室进化提高昆虫High Five细胞中流感病毒血凝素病毒样颗粒的产量
Vaccines (Basel). 2020 Oct 7;8(4):589. doi: 10.3390/vaccines8040589.
8
High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.使用悬浮细胞通过交替切向流(ATF)灌注进行高细胞密度培养以生产甲型流感病毒。
Vaccine. 2014 May 19;32(24):2770-81. doi: 10.1016/j.vaccine.2014.02.016. Epub 2014 Feb 25.
9
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.在一次性使用的轨道式摇床生物反应器中,使用 ATF 或 TFF 灌注系统生产甲型流感病毒。
Vaccine. 2019 Nov 8;37(47):7011-7018. doi: 10.1016/j.vaccine.2019.06.005. Epub 2019 Jun 29.
10
Intensified Influenza Virus Production in Suspension HEK293SF Cell Cultures Operated in Fed-Batch or Perfusion with Continuous Harvest.在采用补料分批培养或连续收获的灌注培养方式操作的悬浮HEK293SF细胞培养物中增强流感病毒的产生。
Vaccines (Basel). 2023 Dec 5;11(12):1819. doi: 10.3390/vaccines11121819.

引用本文的文献

1
The Bioengineering of Insect Cell Lines for Biotherapeutics and Vaccine Production: An Updated Review.用于生物治疗和疫苗生产的昆虫细胞系生物工程:最新综述
Vaccines (Basel). 2025 May 23;13(6):556. doi: 10.3390/vaccines13060556.
2
Process intensification of the baculovirus expression vector system using a perfusion process with a low multiplicity of infection at high cell concentrations.利用在高细胞浓度下低感染复数的灌注工艺强化杆状病毒表达载体系统。
Biotechnol Prog. 2025 May-Jun;41(3):e3527. doi: 10.1002/btpr.3527. Epub 2025 Jan 23.
3
Continuous Production of Influenza VLPs Using IC-BEVS and Multi-Stage Bioreactors.

本文引用的文献

1
Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality.通过在线控制细胞比灌注速率实现高CHO细胞密度种子强化的自动化及其对N级接种物质量的影响。
J Biotechnol. 2021 Jul 20;335:65-75. doi: 10.1016/j.jbiotec.2021.06.011. Epub 2021 Jun 4.
2
Integrating high cell density cultures with adapted laboratory evolution for improved Gag-HA virus-like particles production in stable insect cell lines.将高密度细胞培养与适应性实验室进化相结合,以提高稳定昆虫细胞系中 Gag-HA 病毒样颗粒的产量。
Biotechnol Bioeng. 2021 Jul;118(7):2536-2547. doi: 10.1002/bit.27766. Epub 2021 Apr 8.
3
使用昆虫细胞杆状病毒表达系统(IC-BEVS)和多级生物反应器连续生产流感病毒样颗粒(VLPs)
Biotechnol Bioeng. 2025 Apr;122(4):846-857. doi: 10.1002/bit.28925. Epub 2025 Jan 17.
4
Insect cell production of chimeric virus-like particles based on human immunodeficiency virus GAG proteins and yellow fever virus envelope protein.基于人类免疫缺陷病毒GAG蛋白和黄热病病毒包膜蛋白的嵌合病毒样颗粒的昆虫细胞生产。
Braz J Microbiol. 2024 Dec;55(4):3187-3197. doi: 10.1007/s42770-024-01509-5. Epub 2024 Sep 10.
5
Adaptive Laboratory Evolution to Improve Recombinant Protein Production Using Insect Cells.利用昆虫细胞进行适应性实验室进化以提高重组蛋白生产。
Methods Mol Biol. 2024;2829:79-90. doi: 10.1007/978-1-0716-3961-0_6.
6
Tailored Viral-like Particles as Drivers of Medical Breakthroughs.定制病毒样颗粒作为医学突破的驱动力。
Int J Mol Sci. 2024 Jun 18;25(12):6699. doi: 10.3390/ijms25126699.
7
Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles.通过在病毒样颗粒上展示重组神经氨酸酶提高流感病毒候选疫苗的效力。
Front Immunol. 2024 Jun 10;15:1425842. doi: 10.3389/fimmu.2024.1425842. eCollection 2024.
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.
病毒样颗粒:制备、免疫原性及其作为纳米疫苗和药物纳米载体的作用。
J Nanobiotechnology. 2021 Feb 25;19(1):59. doi: 10.1186/s12951-021-00806-7.
4
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant.新冠病毒:诺瓦瓦克斯疫苗对英国变种的效力为86%,对南非变种的效力为60%。
BMJ. 2021 Feb 1;372:n296. doi: 10.1136/bmj.n296.
5
Low Shear Stress Increases Recombinant Protein Production and High Shear Stress Increases Apoptosis in Human Cells.低剪切应力增加重组蛋白产量,高剪切应力增加人细胞凋亡。
iScience. 2020 Oct 7;23(11):101653. doi: 10.1016/j.isci.2020.101653. eCollection 2020 Nov 20.
6
Improving Influenza HA-Vlps Production in Insect High Five Cells via Adaptive Laboratory Evolution.通过适应性实验室进化提高昆虫High Five细胞中流感病毒血凝素病毒样颗粒的产量
Vaccines (Basel). 2020 Oct 7;8(4):589. doi: 10.3390/vaccines8040589.
7
Virus harvesting in perfusion culture: Choosing the right type of hollow fiber membrane.灌流培养中的病毒收获:选择合适的中空纤维膜类型。
Biotechnol Bioeng. 2020 Oct;117(10):3040-3052. doi: 10.1002/bit.27470. Epub 2020 Jul 2.
8
Adaptive laboratory evolution of stable insect cell lines for improved HIV-Gag VLPs production.适用于 HIV-Gag VLPs 生产的稳定昆虫细胞系的适应性实验室进化。
J Biotechnol. 2020 Jan 10;307:139-147. doi: 10.1016/j.jbiotec.2019.10.004. Epub 2019 Nov 4.
9
Perfusion mammalian cell culture for recombinant protein manufacturing - A critical review.哺乳动物细胞灌流培养用于重组蛋白生产——综述
Biotechnol Adv. 2018 Jul-Aug;36(4):1328-1340. doi: 10.1016/j.biotechadv.2018.04.011. Epub 2018 May 5.
10
Principles and approach to developing mammalian cell culture media for high cell density perfusion process leveraging established fed-batch media.利用已有的分批补料培养基开发用于高细胞密度灌注工艺的哺乳动物细胞培养基的原则和方法。
Biotechnol Prog. 2017 Jul;33(4):891-901. doi: 10.1002/btpr.2472. Epub 2017 Apr 13.